Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies

Autor:	Philippe Merviel, Pandora James, Sarah Bouée, Mathilde Le Guillou, Camille Rince, Charlotte Nachtergaele, Véronique Kerlan
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Polycystic ovary syndrome (PCOS) Myo-inositol In vitro fertilization Intracytoplasmic sperm injection (IVF-ICSI) Embryo quality Pregnancy Gynecology and obstetrics RG1-991
Zdroj:	Reproductive Health, Vol 18, Iss 1, Pp 1-8 (2021)
Druh dokumentu:	article
ISSN:	1742-4755
DOI:	10.1186/s12978-021-01073-3
Popis:	Abstract Polycystic ovary syndrome (PCOS) is marked in 30 to 40% by insulin resistance and hyperandrogenism. Myo-inositol (MI) increases insulin sensitivity, decreases hyperandrogenism and improves the menstrual cycle. Its effect during assisted reproductive technologies (ART) has been studied by many authors. We conducted a review of the literature on the impact of MI administration in PCOS women in assisted reproductive technologies. Myo-inositol is effective in normalizing ovarian function, improving oocyte and embryo quality in PCOS, however further evaluations by large multicentre randomized controlled trials are needed to assess the clinical pregnancy and live birth rates in ART.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/e45b2ec58d2f45d98b70ced224a36a65 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.